Citadel Advisors’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
VPM
VCM
Citadel Advisors's G Position: Q1 2026 in Review
Citadel Advisors reduced its Genpact (G) stake by 95% in Q1 2026, selling an estimated $86M and leaving 112,199 shares worth $4.18M. The position accounts for ﹤0.01% of the portfolio, ranked #4642.
Citadel Advisors first reported a position in G in Q2 2013 and has held it in 45 quarters since. The position peaked at $161M in Q2 2025. 516 funds tracked by Wall St. Rank hold G as of Q1 2026.
- Citadel Advisors held 112,199 shares of Genpact worth $4.18M as of Q1 2026.
- Citadel Advisors sold 2,087,445 Genpact shares in Q1 2026, an estimated $86M.
- Genpact made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4642 holding.
- Citadel Advisors first reported a position in Genpact in Q2 2013 and has held it in 45 quarters since.
- Citadel Advisors's Genpact position peaked at $161M in Q2 2025.
- 516 funds tracked by Wall St. Rank held Genpact as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.